Kexing Biopharm Co., Ltd. (SHA:688136)

Kexing Biopharm Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 7, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	9,317	4,323	4,034	4,260	5,617	8,115
Market Cap Growth	46.36%	7.17%	-5.31%	-24.16%	-30.78%	-
Enterprise Value	9,995	5,012	4,566	4,432	5,203	8,278
Last Close Price	46.73	21.83	20.22	21.41	28.13	40.55
PE Ratio	205.97	137.32	-	-	58.23	58.32
PS Ratio	6.66	3.07	3.20	3.24	4.37	6.65
PB Ratio	5.59	2.64	2.47	2.36	2.94	4.43
P/TBV Ratio	6.45	3.07	2.75	2.59	2.98	4.53
P/FCF Ratio	126.22	340.98	-	-	-	-
P/OCF Ratio	67.35	40.53	-	-	59.75	76.61
EV/Sales Ratio	7.14	3.56	3.63	3.37	4.05	6.78
EV/EBITDA Ratio	46.54	27.15	-	-	67.21	39.86
EV/EBIT Ratio	88.85	50.87	-	-	123.25	46.36
EV/FCF Ratio	135.40	395.29	-	-	-	-
Debt / Equity Ratio	0.75	0.75	0.68	0.57	0.32	0.17
Debt / EBITDA Ratio	5.82	6.18	-	-	6.53	1.52
Debt / FCF Ratio	16.95	96.29	-	-	-	-
Asset Turnover	0.45	0.45	0.41	0.44	0.50	0.69
Inventory Turnover	3.02	2.67	1.85	1.71	1.86	1.95
Quick Ratio	1.34	1.28	1.37	2.18	2.09	3.44
Current Ratio	1.50	1.45	1.69	2.62	2.42	3.73
Return on Equity (ROE)	2.46%	1.65%	-11.38%	-5.00%	5.16%	11.01%
Return on Assets (ROA)	2.25%	1.99%	-4.86%	-2.61%	1.02%	6.29%
Return on Capital (ROIC)	2.45%	2.20%	-5.38%	-2.93%	1.13%	7.17%
Return on Capital Employed (ROCE)	4.90%	4.30%	-	-	1.90%	9.30%
Earnings Yield	0.48%	0.73%	-4.72%	-2.12%	1.72%	1.71%
FCF Yield	0.79%	0.29%	-6.90%	-11.39%	-4.95%	-1.02%
Dividend Yield	0.17%	0.37%	-	-	0.36%	0.20%
Payout Ratio	96.22%	138.60%	-	-	29.43%	7.81%
Buyback Yield / Dilution	-1.92%	0.74%	1.21%	-1.93%	-31.59%	-0.17%
Total Shareholder Return	-1.75%	1.10%	1.21%	-1.93%	-31.23%	0.03%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.